The potential role of miRNA therapies in spinal muscle atrophy
Spinal muscular atrophy (SMA) is a neurodegenerative disease caused by low levels of full-length survival motor neuron (SMN) protein due to the loss of the survival motor neuron 1 (SMN1) gene and inefficient splicing of the survival motor neuron 2 (SMN2) gene, which mostly affects alpha motor neuron...
Main Authors: | Gandhi, Gayatri, Abdullah, Syahrilnizam, Foead, Agus Iwan, Yeo, Wendy Wai Yeng |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier BV
2021
|
Online Access: | http://psasir.upm.edu.my/id/eprint/95562/1/The%20potential%20role%20of%20miRNA%20therapies%20in%20spinal%20muscle%20atrophy.pdf |
Similar Items
-
Rehabilitation in spinal muscular atrophy
by: Agus Iwan Foead, et al.
Published: (2019-01-01) -
Drug Discovery of Spinal Muscular Atrophy (SMA) from the Computational Perspective: A Comprehensive Review
by: Li Chuin Chong, et al.
Published: (2021-08-01) -
Dicer-mediated miRNA processing is not involved in controlling muscle mass during muscle atrophy
by: Satoshi Oikawa, et al.
Published: (2021-09-01) -
miRNA targeted signaling pathway in the early stage of denervated fast and slow muscle atrophy
by: Gang Li, et al.
Published: (2016-01-01) -
Regulation of miRNA content. Part 1. Editing miRNA. Тailing miRNA
by: A.E. Abaturov, et al.
Published: (2021-06-01)